Clinical Trial to Evaluate the Influence of Genotype and DDIs of Aspirin on the PK/PD of Clopidogrel and PK of Digoxin

NCT01775839 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

DRUG REACTIONS

Interventions

DRUG: Aspirin+Clopidogrel/Digoxin(oral)
DRUG: Aspirin+Clopidogrel/Digoxin(IV)

Sponsor

Seoul National University Hospital